BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32639004)

  • 1. Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients.
    Chen P; Zhang G; Zhou Q; Li Z
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32639004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.
    Wang LQ; Sun W; Wang Y; Li D; Hu AM
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):271-276. PubMed ID: 30657585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
    Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma.
    Xiao Y; Zhang L; Song Z; Guo C; Zhu J; Li Z; Zhu S
    Med Sci Monit; 2016 Mar; 22():855-62. PubMed ID: 26978735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma.
    Tang Y; Zhao S; Wang J; Li D; Ren Q; Tang Y
    Neurol Sci; 2017 Jun; 38(6):1087-1092. PubMed ID: 28367610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma miR-454-3p as a potential prognostic indicator in human glioma.
    Shao N; Wang L; Xue L; Wang R; Lan Q
    Neurol Sci; 2015 Feb; 36(2):309-13. PubMed ID: 25190548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for Glioma.
    Zhang R; Pang B; Xin T; Guo H; Xing Y; Xu S; Feng B; Liu B; Pang Q
    Mol Neurobiol; 2016 Apr; 53(3):1452-1460. PubMed ID: 25636684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of microRNA-124 predicts poor prognosis in glioma patients.
    Chen T; Wang XY; Li C; Xu SJ
    Neurol Sci; 2015 Jan; 36(1):131-5. PubMed ID: 25112530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of miR-3653 in glioma and its correlations with clinical progression and patient survival.
    Chen Y; Li ZH; Liu X; Liu GX; Yang HM; Wu PF
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6596-6601. PubMed ID: 31378901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Evaluation of Serum MicroRNA-29 Family for Glioma Screening.
    Wu J; Li L; Jiang C
    Mol Neurobiol; 2015 Dec; 52(3):1540-1546. PubMed ID: 25367878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients.
    Shi R; Wang PY; Li XY; Chen JX; Li Y; Zhang XZ; Zhang CG; Jiang T; Li WB; Ding W; Cheng SJ
    Oncotarget; 2015 Sep; 6(29):26971-81. PubMed ID: 26284486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-599 as a potential biomarker for prognosis of glioma.
    Zhu XY; Li GX; Liu ZL
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):294-298. PubMed ID: 29424886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
    Zhang J; Lv J; Zhang F; Che H; Liao Q; Huang W; Li S; Li Y
    J Neurooncol; 2017 Jul; 133(3):553-559. PubMed ID: 28551850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum microRNA-376 family as diagnostic and prognostic markers in human gliomas.
    Huang Q; Wang C; Hou Z; Wang G; Lv J; Wang H; Yang J; Zhang Z; Zhang H
    Cancer Biomark; 2017; 19(2):137-144. PubMed ID: 28211798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of tissue microRNA10b may help predict glioma prognosis.
    Zhang X; Cheng J; Fu L; Li Q
    J Clin Neurosci; 2016 Jul; 29():59-63. PubMed ID: 26988656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker.
    Santangelo A; Imbrucè P; Gardenghi B; Belli L; Agushi R; Tamanini A; Munari S; Bossi AM; Scambi I; Benati D; Mariotti R; Di Gennaro G; Sbarbati A; Eccher A; Ricciardi GK; Ciceri EM; Sala F; Pinna G; Lippi G; Cabrini G; Dechecchi MC
    J Neurooncol; 2018 Jan; 136(1):51-62. PubMed ID: 29076001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating miR-199a-3p in plasma and its potential diagnostic and prognostic value in glioma.
    Chai C; Song LJ; Yang B; Han SY; Li XQ; Li M
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4885-4890. PubMed ID: 27981547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
    Gandhi P; Khare R; Garg N
    J Neurooncol; 2017 Nov; 135(2):255-261. PubMed ID: 28756592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.